Nixon Peabody Trust Co. Has $439,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Nixon Peabody Trust Co. trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 40.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 750 shares of the healthcare conglomerate’s stock after selling 500 shares during the period. Nixon Peabody Trust Co.’s holdings in UnitedHealth Group were worth $439,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of UNH. Tealwood Asset Management Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $2,905,000. Asset Planning Services Inc. LA ADV raised its position in UnitedHealth Group by 1.2% in the third quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after purchasing an additional 150 shares in the last quarter. Sequoia Financial Advisors LLC boosted its holdings in UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after purchasing an additional 3,006 shares in the last quarter. Americana Partners LLC raised its holdings in shares of UnitedHealth Group by 10.8% in the 3rd quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after buying an additional 1,984 shares in the last quarter. Finally, Hennion & Walsh Asset Management Inc. grew its position in UnitedHealth Group by 14.8% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock valued at $5,072,000 after acquiring an additional 1,283 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on UNH shares. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. TD Cowen boosted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Cantor Fitzgerald lifted their price objective on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. HSBC lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, October 17th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Trading Down 0.6 %

UnitedHealth Group stock traded down $3.50 during midday trading on Monday, hitting $588.73. 233,790 shares of the stock were exchanged, compared to its average volume of 3,872,613. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $541.80 billion, a PE ratio of 38.58, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a fifty day simple moving average of $582.84 and a two-hundred day simple moving average of $549.98.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period last year, the business earned $6.56 EPS. The business’s quarterly revenue was up 9.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.